BIOMAT Database Logo BIOMAT Database Logo

Anticardiolipin antibodies in Japanese patients with multiple sclerosis. 1993

T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Hokuyukai Neurology Hospital, Sapporo, Japan.

We evaluated circulating anticardiolipin antibodies (aCL) in 38 Japanese patients who fulfilled the criteria of clinically definite multiple sclerosis (MS), using a newly developed EIA system with aCL-cofactor. Two of 38 patients (5.3%) had a aCL-cofactor-dependent positive serology, and differences compared with findings in controls were statistically significant. The 2 aCL-positive patients had similar clinical features with acute transverse myelopathy (ATM), optic neuropathy (OPN), normal cranial MRI and negative oligoclonal IgG bands (OCBs) in the cerebrospinal fluid (CSF). Among the 38 patients, 3 had ATM, OPN, normal cranial MRI and negative OCBs, hence, in a significant number of the patients (2/3; 67%) with these distinctive features, serology for aCL was positive. Therefore, they may have another condition associated with aCL, masquerading as MS. Serological testing for aCL with aCL-cofactor is recommended for the patients with clinical diagnosis of MS, especially for those showing OPN and ATM during the clinical course, and in Asian peoples where the incidence of ATM and OPN is relatively high among the patients with diagnosis of MS.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009901 Optic Nerve Diseases Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect. Cranial Nerve II Diseases,Foster-Kennedy Syndrome,Optic Disc Disorders,Optic Disk Disorders,Optic Neuropathy,Second Cranial Nerve Diseases,Cranial Nerve II Disorder,Neural-Optical Lesion,Disc Disorder, Optic,Disk Disorder, Optic,Disorder, Optic Disc,Foster Kennedy Syndrome,Lesion, Neural-Optical,Neural Optical Lesion,Neural-Optical Lesions,Neuropathy, Optic,Optic Disc Disorder,Optic Disk Disorder,Optic Nerve Disease,Optic Neuropathies,Syndrome, Foster-Kennedy
D003095 Collagen Diseases Historically, a heterogeneous group of acute and chronic diseases, including rheumatoid arthritis, systemic lupus erythematosus, progressive systemic sclerosis, dermatomyositis, etc. This classification was based on the notion that "collagen" was equivalent to "connective tissue", but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term "collagen diseases" now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (From Cecil Textbook of Medicine, 19th ed, p1494) Collagen Disease,Disease, Collagen,Diseases, Collagen
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005073 Evoked Potentials, Somatosensory The electric response evoked in the CEREBRAL CORTEX by stimulation along AFFERENT PATHWAYS from PERIPHERAL NERVES to CEREBRUM. Somatosensory Evoked Potentials,Evoked Potential, Somatosensory,Somatosensory Evoked Potential
D005074 Evoked Potentials, Visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways. Visual Evoked Response,Evoked Potential, Visual,Evoked Response, Visual,Evoked Responses, Visual,Potential, Visual Evoked,Potentials, Visual Evoked,Response, Visual Evoked,Responses, Visual Evoked,Visual Evoked Potential,Visual Evoked Potentials,Visual Evoked Responses
D005260 Female Females

Related Publications

T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Lupoid sclerosis with raised anticardiolipin antibodies.
April 1995, The Journal of the Association of Physicians of India,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis.
January 1995, Autoimmunity,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Anticardiolipin antibodies in systemic sclerosis.
August 1986, Arthritis and rheumatism,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Anticardiolipin antibodies in systemic sclerosis.
July 1991, Journal of the American Academy of Dermatology,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
[A case of myasthenia gravis associated with multiple sclerosis and positive anticardiolipin antibodies].
May 1993, Rinsho shinkeigaku = Clinical neurology,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
A case of multiple sclerosis associated with rheumatoid arthritis and positive anticardiolipin antibodies.
April 2003, Annals of the rheumatic diseases,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Anticardiolipin antibodies are not a useful screening tool in a nonselected large group of patients with multiple sclerosis.
March 2001, Annals of neurology,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Coronavirus antibodies in patients with multiple sclerosis.
January 1981, Advances in experimental medicine and biology,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Measles antibodies in patients with multiple sclerosis.
July 1967, Neurology,
T Fukazawa, and F Moriwaka, and M Mukai, and T Hamada, and T Koike, and K Tashiro
Gluten antibodies in patients with multiple sclerosis.
April 1984, Human nutrition. Applied nutrition,
Copied contents to your clipboard!